Transient inhibition of lysosomal functions potentiates nucleic acid vaccines
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2306465120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Chunxi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC 27708. Hauptthemen laut MEDLINE: Vaccines, Vaccines, DNA, Nucleic Acids, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Nucleic acid vaccines have shown promising results in the clinic against infectious diseases and cancers. To robustly improve the vaccine efficacy and safety, we developed an approach to increase the intracellular stability of nucleic acids by transiently inhibiting lysosomal function in targeted tissues using sucrose. To achieve efficient and localized delivery of sucrose in animals, we designed a biomimetic lipid nanoparticle (LNP) to target the delivery of sucrose into mouse muscle cells. Using this approach, viral antigen expression in mouse muscle after DNA vaccination was substantially increased and prolonged without inducing local or systemic inflammation or toxicity. The same change in antigen expression would be achieved if the vaccine dose could be increased by 3,000 folds, which is experimentally and clinically impractical due to material restrictions and severe toxicity that will be induced by such a high dose of nucleic acids. The increase in antigen expression augmented the infiltration and activation of antigen-presenting cells, significantly improved vaccine-elicited humoral and T cell responses, and fully protected mice against the viral challenge at a low dose of vaccine. Based on these observations, we conclude that transient inhibition of lysosome function in target tissue by sucrose LNPs is a safe and potent approach to substantially improve nucleic acid-based vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Duke University, Durham, NC 27708.
- Duke Human Vaccine Institute, Duke University, Durham, NC 27708.
- Department of Medicine, Duke University School of Medicine, Durham, NC 27708.
- Center for vaccine research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
- Department of Pediatrics, Duke University School of Medicine, Durham, NC 27708.
ORCID-Profile: Thomas H Oguin, Andrew N Macintyre, Gregory D Sempowski, Yifei Wang, M Anthony Moody, Fan Yuan
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wang, C., Karlsson, A., Oguin, T. H., Macintyre, A. N., Sempowski, G. D., McCarthy, K. R., Wang, Y., Moody, M. A., & Yuan, F. (2023). Transient inhibition of lysosomal functions potentiates nucleic acid vaccines. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2306465120
Vancouver
Wang C, Karlsson A, Oguin TH, Macintyre AN, Sempowski GD, McCarthy KR, et al. Transient inhibition of lysosomal functions potentiates nucleic acid vaccines. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2306465120
BibTeX
@article{Wang2023,
author = {Wang, Chunxi and Karlsson, Amelia and Oguin, Thomas H and Macintyre, Andrew N and Sempowski, Gregory D and McCarthy, Kevin R and Wang, Yifei and Moody, M Anthony and Yuan, Fan},
title = {Transient inhibition of lysosomal functions potentiates nucleic acid vaccines},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2306465120}
}
EUVIMED